Equity Overview
Price & Market Data
Price: $0.87
Daily Change: +$0.0056 / 0.64%
Daily Range: $0.821 - $0.89
Market Cap: $12,000,480
Daily Volume: 37,864
Performance Metrics
1 Week: 18.71%
1 Month: -5.04%
3 Months: 14.84%
6 Months: 12.32%
1 Year: -98.67%
YTD: -97.79%
Company Details
Employees: 5
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.